Who Classification Of Skin Tumours | Proven

The (5th Edition, 2025) is the authoritative global standard for diagnosing and categorizing cutaneous neoplasms. Also known as the "Blue Books," this edition shifts toward a more integrated, multidisciplinary approach that combines traditional histopathology with advanced molecular genetics and immunohistochemistry. Key Structural & Conceptual Changes

: Each tumour entry includes clear "essential" diagnostic features and "desirable" criteria to improve diagnostic reliability worldwide. Major Clinical Updates by Category 1. Melanocytic Neoplasms

: The term "variant" is now reserved strictly for genetic alterations in DNA sequences, rather than being used to describe morphological subtypes. WHO Classification of Skin Tumours

: Updates focus on high-risk subtypes. Sarcomatoid differentiation is now the primary acknowledged uncommon subtype of Squamous Cell Carcinoma (SCC).

: A dedicated new section covers epithelial tumours derived specifically from the nail bed. The (5th Edition, 2025) is the authoritative global

: A new chapter focusing on the adverse prognostic implications of systemic cancers metastasizing to the skin.

: Significant updates were made to dendritic cell and histiocytic neoplasms, as well as T-cell and NK-cell disorders. Major Clinical Updates by Category 1

Detailed information and purchasing options for the full volume are available through the IARC Publications or Amazon .